BioMedWire Stocks

How Pharmacies Should Prepare for Future Health Care Landscape

The healthcare landscape has changed significantly, especially since the coronavirus pandemic, and will continue to do so as technology advances. The pandemic highlighted how crucial pharmacists were in keeping individuals healthy. It has also become clear that pharmacies help mold health outcomes in a number of ways.

However, to successfully move forward in the industry, pharmacies will need to step it up a notch or two. They can start to do so by considering how certain changes may affect their daily operations and make the necessary adjustments. For instance, the shift toward value-based care models is important to consider as it aligns financial incentives with patient outcomes as well as experiences.

Patients’ having a positive experience with their pharmacies affects every shareholder in the healthcare ecosystem. Below, we look at a few tools pharmacies can adopt to revamp their links with patients and other partners and future-proof their enterprises. This will assure longevity while also affording their clients the best standard of care.

Patient engagement support

It is estimated that a patient visits their pharmacist 12 times more often than their primary care physician. This highlights the unique position that pharmacies in the community are in to take on a bigger role in preventative and primary care with the right support tools for engagement.

These tools may include education campaigns, applications that send messages and reminders set at pre-established times based on the history of a patient’s medication fill.

Collaboration

Management platforms support workflows in pharmacies and help make the process of filling prescriptions more efficient. Pharmacies wanting to navigate the changing landscape with ease should also strive to provide integrated solutions that allow total visibility into everything, ranging from payer-funded clinical interventions to clinical opportunities.

Growth support and enablement

With new regulations materializing and technology evolving, pharmacies will need to improve their flexibility. This can be done using technology that supports business growth.

For instance, if pharmacies would like to provide additional revenue services such as blood pressure monitoring, blood glucose monitoring, immunization or even urinalysis through telehealth platforms, they will need tools to assist them with documenting services, coding and sharing data with their partners.

Now is the time to look into improving these processes and technologies, especially with the role of pharmacies in patient care evolving and telehealth platforms becoming more popular. Finding and implementing the right solutions to encourage better collaboration is a crucial aspect of advancing and ensuring continued success for pharmacies.

Health services organizations such as Progressive Care Inc. (OTCQB: RXMD) have a big role to play in helping pharmacies to evolve as the sector in which they operate also evolves.

NOTE TO INVESTORS: The latest news and updates relating to Progressive Care Inc. (OTCQB: RXMD) are available in the company’s newsroom at https://ibn.fm/RXMD

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Study Identifies Genetic Marker Helpful in Guiding Brain Tumor Treatment

Researchers at the University of Kentucky have identified a key genetic biomarker that treatment teams…

21 hours ago

New AI-Based Speech Tool Detects Possibility of Parkinson’s Disease

Computer scientists have designed an AI-based speech screening tool that could help people ascertain whether…

2 days ago

Why Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Is ‘One to Watch’

Izotropic is the only commercial entity with exclusive global rights to the Breast CT technology…

4 days ago

Study Discovers That Autoantibodies in Patients Could Boost Cancer Immunotherapy

For years, oncologists have been baffled by why checkpoint inhibitors work for some cancer patients…

4 days ago

Clene Inc. (NASDAQ: CLNN) Offers Investors a Compelling Entry into the Growing ALS Market with Key FDA Milestones for Lead Drug Candidate

Clene is progressing toward a potential FDA accelerated approval for its ALS (Amyotrophic Lateral Sclerosis)…

5 days ago

Survey Finds That US Healthcare Workers Worry About Personal Safety

According to a new survey, approximately 60% of workers in the U.S. healthcare sector are…

1 week ago